VTE Banner Image

VENOUS THROMBOEMBOLISM: immerse program™

CHALLENGE

Venous Thromboebmolism (VTE) affects up to one million Americans and contributes to approximately 200,000 deaths annually. All hospitalized patients are at increased risk for venous thromboembolism. Deep vein thrombosis (DVT)-related pulmonary embolism (PE) is the most common cause of preventable death in a hospital setting. Venous thromboembolism events represent a major cost burden, with reimbursement for DVT and PE events averaging $7,700 and healthcare cost of a DVT or PE event averaging over $12,000.

The MSC Venous Thromboembolism Quality Solution: Immerse Program™ focuses on prevention, early identification, and initial treatment, based on the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines for Prevention of Venous Thromboembolism (9th edition, 2012) and The Joint Commission’s National Consensus Standards for Prevention and Care of Venous Thromboembolism (2008). The VTE Quality Solution is authored by Graham Pineo, MD, FRCPC, FAFP.
Subscribe now to MSC for updates!

CLINICAL APPLICABILITY

VTE following certain orthopedic procedures is considered a hospital-acquired condition (HAC) by the Centers for Medicare and Medicaid (CMS) and therefore not eligible for reimbursement
VTE events represent a major cost burden for hosptials, with an average cost of $16,644 for a PE and a readmission rate of up to 14%
A 300-bed hospital will see approximately 150 VTE cases per year, of which 50-75 percent are avoidable

SOLUTION

Medical Simulation Corporation’s Venous Thromboembolism Course educates participants on the CHEST guidelines for prophylaxis, early recognition of signs and symptoms, and initial treatment recommendations. General information on fibrinolysis, as well as inferior vena cava (IVC) filters are also included. This course is suitable for physicians, nurses, and other allied healthcare providers who care for medical and surgical patients.

RESULTS

Improve compliance with CMS and Joint Commission goals for medical and surgical patient VTE prophylaxis, translating to improved patient outcomes and cost savings.
Improve Hospital Acquired Conditions scores to achieve CMS incentives, avoid penalties and improve profitability.